Jun 30, 2010

United Therapeutics Q2 2010 Earnings Report

Total Revenue
$137M
Previous year: $164M
-16.0%
EPS
$0.67
Previous year: $0.21
+219.0%
Gross Profit
$121M
Previous year: $73.9M
+63.5%
Cash and Equivalents
$285M
Previous year: $134M
+113.8%
Free Cash Flow
$32.5M
Previous year: $7.58M
+328.7%
Total Assets
$1.19B

United Therapeutics

United Therapeutics